Antimicrobial Resistance News and Research

RSS

New frontiers in medicine: COVID-19 lessons push for multidisciplinary collaboration

Researchers highlight the need for multidisciplinary collaboration in medicine, especially in addressing transmissible illnesses, precision medicine, and data science, as learned from the COVID-19 pandemic.

28 May 2024

Research project targets plastic particles and climate change as driving factors for antimicrobial resistance

A research project based at Heidelberg University and Heidelberg University Hospital targets plastic particles and climate change as driving factors for the spread of antimicrobial resistance (AMR) in the environment.

27 May 2024

Personalized phage therapy successfully treats antibiotic-resistant infections in animals

A new study demonstrates an advance in treating antibiotic-resistant infections in animals through personalized phage therapy.

27 May 2024

Advanced techniques reveal plectasin's velcro-like action against bacteria

A small antibiotic called plectasin uses an innovative mechanism to kill bacteria. By assembling into large structures, plectasin latches onto its target on the bacterial cell surface comparable to how both sides of Velcro form a bond.

25 May 2024

New small molecule offers hope in combating antibiotic resistance

Researchers from the University of Oxford have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics.

24 May 2024

UMSOM receives $3.96 million grant for maternal vaccine against neonatal sepsis

University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants.

23 May 2024

WHO report highlights rising STI rates and insufficient progress in HIV and hepatitis control

Global HIV, viral hepatitis epidemics and sexually transmitted infections (STIs) continue to pose significant public health challenges, causing 2.5 million deaths each year, according to a new WHO report - Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030.

22 May 2024

MHRA receives £1.8 million to boost antimicrobial innovation and diagnostics

Backed by a new award of £1.8 million, the Medicines and Healthcare products Regulatory Agency (MHRA) is to establish a dedicated team to provide regulatory scientific support for innovators creating novel antimicrobials and diagnostics as part of a programme led by the Department of Health and Social Care (DHSC) to support the international community in tackling the growing threat of antimicrobial resistance (AMR).

20 May 2024

WHO updates Bacterial Priority Pathogens List to combat antimicrobial resistance

The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritization.

20 May 2024

AMR Multi-Stakeholder Partnership Platform develops key recommendations for action on antimicrobial resistance

Antimicrobial resistance (AMR) is one of the top global public health and development threats. According to the World Health Organisation (WHO), an estimated 4.95 million deaths were associated with AMR in 2019, including 1.27 million deaths attributable to bacterial AMR.

17 May 2024

AI uncovers gaps in global antimicrobial resistance research

Artificial Intelligence (AI) has helped identify knowledge, methodological and communication gaps in global Antimicrobial Resistance (AMR) research.

17 May 2024

SMART researchers identify key mechanism behind artemisinin resistance in malaria

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Massachusetts Institute of Technology (MIT), Columbia University Irving Medical Center (CUIMC), and Nanyang Technological University, Singapore (NTU Singapore), have discovered a link between malaria parasites' ability to develop resistance to antimalarial drugs – specifically artemisinin (ART) – through a cellular process called transfer Ribonucleic acid (tRNA) modification.

16 May 2024

£85 million funding to support the international community in tackling antimicrobial resistance

Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.

16 May 2024

WHO issues landmark guidelines for preventing catheter-associated infections

The World Health Organization publishes the first global guidelines to prevent the occurrence of bloodstream and other infections caused by use of catheters placed in minor blood vessels during medical procedures.

10 May 2024

Tailored vaccine may hold the key to treating eczema in children

New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children.

8 May 2024

New plan to tackle antimicrobial resistance launched

A new plan to tackle antimicrobial resistance (AMR), a global issue that makes infections difficult or impossible to treat, has been launched today.

7 May 2024

Purdue researcher receives $2.4 million NIH grant to combat antimicrobial resistance in lung infections

Qi "Tony" Zhou, a researcher in Purdue University's College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that have established a resistance to antimicrobial drugs.

6 May 2024

Gut bacteria and urinary infections linked, offering new angles for treatment

A study in eClinicalMedicine explores the relationship between gut microbiota, urinary tract colonization, and recurrent urinary tract infections (rUTI), suggesting the cross-habitation of uropathogenic E. coli as a significant mechanism in rUTI recurrence.

30 Apr 2024

Age and sex impact antimicrobial resistance levels, research shows

New research presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona 27-30 April) shows that levels of resistance to antimicrobials (AMR) varies with age and sex, with age in particular showing substantial variation both between and within countries.

29 Apr 2024

Study reveals genetic divergence and drug resistance mechanisms in two critical superbugs

Infectious diseases caused by pathogenic strains of bacteria are a global cause of morbidity and mortality. Hospital-acquired infections caused by Klebsiella pneumonia and Pseudomonas aeruginosa were found vulnerable during the COVID-19 pandemic.